[14C]-Linerixibat–related radioactivity after intravenous infusion of radiolabeled microdose
| Component | Nominal Retention Time | % Radioactivity | |||
|---|---|---|---|---|---|
| Plasma | Urine | Bile | Feces | ||
| min | |||||
| Impurity E | 35.2 | 0.68 | 1.46 | 1.13 | NA |
| Linerixibat | 36.4 | 85.64 | 97.28 | 96.22 | 90.57 |
| P3a | 42.0 | 1.24 | NA | NA | NA |
| P4a | 47.4 | 1.78 | NA | NA | NA |
NA, not assessed.
↵aIdentity unknown.